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The pathogen Pseudomonas aeruginosa causes serious damage in immunocompromised patients by secretion of various virulence
factors, among them the quorum sensing N-(3-oxododecanoyl)-L-homoserine lactone (3OC12) and the redox-active pyocyanin
(PCN). Paraoxonase-2 (PON2) may protect against P. aeruginosa infections, as it eﬃciently inactivates 3OC12 and diminishes
PCN-induced oxidative stress. This defense could be circumvented because 3OC12 mediates intracellular Ca2+-rise in host cells,
which causes rapid inactivation and degradation of PON2. Importantly, we recently found that the PON2 paralogue PON3
prevents mitochondrial radical formation. Here we investigated its role as additional potential defense mechanism against P.
aeruginosa infections. Our studies demonstrate that PON3 diminished PCN-induced oxidative stress. Moreover, it showed clear
anti-inﬂammatory potential by protecting against NF-κB activation and IL-8 release. The latter similarly applied to PON2.
Furthermore, we observed a Ca2+-mediated inactivation and degradation of PON3, again in accordance with previous ﬁndings
for PON2. Our results suggest that the anti-oxidative and anti-inﬂammatory functions of PON2 and PON3 are an important part
of our innate defense system against P. aeruginosa infections. Furthermore, we conclude that P. aeruginosa circumvents PON3
protection by the same pathway as for PON2. This may help identifying underlying mechanisms in order to sustain the protection
aﬀorded by these enzymes.
1.Introduction
The bacterium Pseudomonas aeruginosa is an opportunistic
nosocomial pathogen, which infects the pulmonary tract of,
for example, immunocompromised patients or those suf-
fering from cystic ﬁbrosis, pneumonia, burn wounds, HIV,
or cancer chemotherapy [1]. The infection causes serious
damageinthehost, complicatedbyanoftenhinderedantibi-
otic treatment due to multiresistances and bioﬁlm formation
thatprovidesphysicalprotection.Furthermore,P. aeruginosa
secrets a variety of virulence factors to regulate bacterial
communication and weaken the defense mechanisms of
the infected host. Two important factors are the quorum
sensing signal N-(3-oxododecanoyl)-L-homoserine lactone
(3OC12) and the redox-active pyocyanin (PCN). 3OC12 is
a mediator of the cell-density-dependent signaling system
known as quorum sensing, by which the bacteria coordinate
their gene expression. If bacterial density and 3OC12 con-
centration exceed a certain threshold, the bacteria become
virulent by expression of virulence factors (immunogenic
exoenzymes and toxins) and by inducing inﬂammation.
The lactone 3OC12 has numerous immunomodulatory and
inﬂammatory properties, such as an inhibitory eﬀect on
dendritic cells and T-cell activation [2], proinﬂammatory2 Journal of Lipids
induction of IL-6 and IL-8 in airway epithelial cells and
lung ﬁbroblasts [3], and promoting apoptosis [4, 5]. Studies
in mice have shown that 3OC12 is a critical determinant
for bacterial colocalization and the establishment of chronic
lung infections [6]. Therefore, the development of quorum
sensing inhibitors would be a major advance in the ability to
combat P. aeruginosa infections [7, 8].
The production of the virulence factor PCN is positively
regulated by quorum sensing signals including 3OC12 [9].
PCN causes oxidative stress and has a broad range of eﬀects
on airway epithelial cells such as cellular senescence and
ciliary dyskinesia, induction of IL-8 secretion, decrease of
glutathione levels, and inhibition of catalase activity [9, 10].
The redox-activity of PCN is central to the damage observed
in exposed host cells. The zwitterionic PCN transfers
electrons from reduced NADH or NADPH in the cytosol
to molecular oxygen leading to production of superoxide
(O2
−), which is converted to H2O2 [11]. Additionally, PCN
causes a disturbance of the antimicrobial Duox/SCN
−/LPO-
system,byconsumingthesamesubstrates(molecularoxygen
and NADPH) [12]. The requirement for PCN in lung
infection was demonstrated in an acute pneumonia mice
model: P. aeruginosa strains lacking the ability to produce
PCN are much more rapidly cleared from lungs and showed
less virulence than the wild-type strain [13].
The paraoxonase family consists of the three mem-
bers PON1, PON2, and PON3, which exhibit about 70%
similarity at the amino acid level [14]. PON1 is asso-
ciated with HDL in serum, whereas PON2 and PON3
are intracellular proteins. In contrast to PON2, which is
ubiquitously expressed, PON3 appears restricted to fewer
tissues/cells; its expression in cells relevant to cardiovascular
diseases is contradictory, because Marsillach et al. [15]f o u n d
PON3 by immunohistochemistry in human vascular walls
and macrophages, while our studies revealed absence in
macrophages, endothelial, smooth muscle, and many other
cell types [16]. All three PONs share a lactonase activity
with distinct and overlapping substrate speciﬁcities [17–19].
PON2 dominantly hydrolyzes 3OC12 presumably resulting
in the ability to interfere with quorum sensing, which may
signiﬁcantly attenuate bacterial virulence of P. aeruginosa.
In support of this concept, epithelial tracheal cells from
PON2 deﬁcient mice showed a reduced ability to inactivate
3OC12 [20]. In addition to its lactonase activity, PON2 is a
major anti-oxidative protein that diminishes mitochondrial
superoxide production and thus considerably determines
cell survival [21–23]. In particular, it has also been shown
that PON2 diminishes PCN-induced ROS production in
human epithelial cells [24]. Intriguingly, 3OC12 causes a
rapid Ca2+-mediated PON2 inactivation and degradation in
cultured cells by a yet unknown mechanism, which enables
3OC12 to protect itself from its hydrolysis by PON2 [25].
As a consequence, 3OC12 potentiates the formation of ROS
induced by PCN, revealing a potential mechanism by which
the bacterium may circumvent the protection aﬀorded by
PON2 [25].
Our recent studies demonstrated that PON3, much like
PON2, reduced the generation of mitochondrial superox-
ide. We also revealed that PON3 was frequently found
overexpressed in tumors. There, it reduced susceptibility to
chemotherapeutics and reduced apoptosis, in line with the
central involvement of mitochondrial ROS to cell death [16].
Hence,wehypothesizedthatPON3attenuatedPCN-induced
oxidative stress, which was tested here for the ﬁrst time. Our
studies also included inﬂammatory pathways subsequent to
PCN stimulation, that is, NF-κB activation and secretion of
variouscytokines.Ourresultssupporttheconceptofmarked
anti-inﬂammatory roles for PON2 and PON3. Finally, we
foundthatbothenzymes,PON2andPON3,wereinactivated
a n dd e g r a d e di nr e s p o n s et oC a 2+-disturbances caused by
3OC12. Identifying the underlying pathway(s) by which the
PONs are downregulated may reveal a therapeutic target,
whichcouldbeexploitedtohelpsustainorenhancethehost’s
PON2 and PON3 activities. Such a clinical intervention
could be of great beneﬁt in the defense against P. aeruginosa
infections.
2.MaterialandMethods
2.1.CellCultureandMaterial. HumanendothelialEA.hy926
cells obtained from the ATCC were cultured in Dul-
becco’s modiﬁed Eagle’s medium without Phenol Red
(Sigma, St. Louis, MO, USA) containing sodium pyru-
vate (PAA Laboratories, Pasching, Austria), antibiotics pen-
icillin/streptomycin, hypoxanthine/aminopterin/thymidine
supplement, L-Glutamine (Invitrogen, Carlsbad, CA, USA),
and 10% (v/v) fetal calf serum (PAA). Human PON2
or PON3 cDNA was subcloned into pDsRed-Express-N1
or pEGFP-N1 plasmids (Clontech). Stable cell lines, plas-
mids, and transfection procedures were described before
[25, 26]. HEK293 and A549 cells were from the Ger-
man Collection of Microorganisms and Cell Cultures.
HEK293 received the same medium as EA.hy 926, but
without hypoxanthine/aminopterin/thymidine supplement.
A549 cells received the same medium as HEK293, but
5% serum. Cells were cultured at 37◦C in a humidiﬁed
atmosphere with 5% CO2 (10% for EA.hy 926). Pyocyanin
was purchased from Cayman Chemical Company (Ann
Arbor, MI, USA); Mito-HE and thapsigargin were from
Molecular Probes; L-012 was from Wako Chemicals (Neuss,
G e r m a n y ) ,a n da l lo t h e rr e a g e n t sw e r ef r o mS i g m a .
2.2. ELISA. EA.hy 926 cells were seeded one day prior
to stimulation in 6-well dishes at 80% conﬂuency (5 ×
105/well). Treatment occurred in 1.5mL medium with-
out FCS for 16h with or without pyocyanin (10μM).
Cell supernatants were taken for Multi-Analyte ELISArray
Kit for human inﬂammatory cytokines (SA Biosciences,
Frederick, MD, USA) according to the supplier’s instruc-
tions. Absorbance was determined using a FluoStar Optima
microplate reader (BMG Labtechnologies). Corrected OD
was calculated by subtracting the A450 reading by the A570
readingtoclearanyminoropticalimperfectionsintheELISA
plate.
2.3. Reporter Gene Assays. Cells at 80% conﬂuency were
cotransfected with pcDNA3-HA or pcDNA3-PON2-HA or
pEGFP-N1 or pEGFP-N1-PON3 and a plasmid allowingJournal of Lipids 3
for constitutive renilla luciferase expression (a kind gift of
H. Kleinert, University Medical Centre, Mainz) and the
NF-κB reporter plasmid (pGL4.32[luc2P/NF-κB-RE/Hygro]
from Promega, Madison, WI, USA). We used Nanofect-
inTM (PAA) for transfection according to the supplier’s
instructions. Cells were treated 24h after transfection with
pyocyanin (100μM) for 4h. Subsequently the NF-κBa c t i vi ty
was measured by Dual-Luciferase Reporter Assay System
(Promega) according to the supplier’s instructions.
2.4.qRT-PCR. RNAisolationandcDNAgenerationwasper-
formed as reported previously [21]. PON3 expression level
was determined by quantitative real-time PCR normalized
to GAPDH as described before [21]. The following Taqman
primers (Euroﬁns, MWG Operon) were used: PON3: sense
5 -TGGGATCACAGTCTCAGCAG-3 ; antisense 5 -TCC-
ACTAAGGTGCCCAACTG-3 ;p r o b e5  -TGGAAAAAC-
ATGATAACTGGGA-3 ; GAPDH: sense 5 -CAACAGCCT-
CAAGATCATCAGC-3 ; antisense 5 -TGGCATGGACTG-
TGGTCATGAG-3 ;p r o b e5  -CCTGGCCAAGGTCATCCA-
TGACAAC-3 .
2.5. Western Blotting. Preparation of lysates, SDS-PAGE, and
Western blotting was performed as reported previously [25].
Rabbit-anti-PON3 polyclonal antibody was used at 1:750
(Sigma, St. Louis, MO, USA), rabbit-anti-PON2 [26] used at
1:2000. Mouse-anti-GAPDH 6C5 (Santa Cruz, Santa Cruz,
CA, USA) and HRP-conjugated secondary antibodies were
from Sigma or Cell Signaling Technology. Immunodetected
proteins were visualized and quantitatively evaluated as
described before [24].
ROS detection and determination of lactonase and
lovastatinase activities were performed as described before
[17, 24, 27].
2.6. Software, Statistics, and Image Acquisition. GraphPad
Prism-5wasusedforcalculations,statisticalevaluationusing
1-/2-way ANOVA with Bonferroni’s multiple comparisons
posttest (see Figures 1–6). P<0.05 was considered
signiﬁcant. Adobe Photoshop software was used for image
acquisition. If necessary, only brightness and/or contrast
were changed simultaneously for all areas of any blot.
3. Results
3.1. PON2 and PON3 Protect Cells from PCN-Induced
ROS and Inﬂammatory Responses. PCN is essential for P.
aeruginosa infections in vivo and causes oxidative stress,
which leads to serious damage of airway epithelial cells
[12, 13]. We recently found that PON2 decreases ROS
production in EA.hy 926 cells in response to treatment with
PCN [24]. Given the high degree of homology between
the paraoxonases and previous descriptions of PON3 anti-
oxidative eﬀects, we wanted to test whether PON3 also
attenuated PCN-induced ROS production. This was mea-
sured by loading na¨ ıve or PON3 overexpressing cells with
the ﬂuorescent ROS indicator carboxy-H2DCFDA followed
by stimulation with PCN (2.4μM); PON2 overexpressing
cells were used in these (and subsequent) studies for
comparison. As with PON2, PON3 overexpression aﬀorded
a marked protection against PCN-induced oxidative stress
(Figure 1(a)). To control for a potential direct oxidation
of carboxy-H2DCFDA by PCN, an unwanted eﬀect by the
GFP tag and for eﬀects speciﬁc to HEK293 cells, we also
used the luminol derivate L-012 to report ROS in EA.hy
926 cells overexpressing a PON3-dsRed construct. As with
HEK293 PON3-GFP cells, the EA.hy 926 PON3-GFP and
PON3-dsRed cells show decreased ROS production after
PCN treatment (Figure 1(b)).
PCNalsoleadstoaproinﬂammatoryresponsebycausing
the release of interleukins, which might be triggered by
activation of NF-κB[ 12, 28]. To test for anti-inﬂammatory
eﬀects of PON2 and PON3, we next addressed activation of
the NF-κB pathway in lung epithelial A549 cells in response
to PCN treatment. Employing gene reporter studies, we
cotransfected A549 cells with (i) an NF-κB ﬁreﬂy luciferase
reporter plasmid, (ii) a renilla luciferase expression vector
for normalization purposes, and (iii) a PON2 or PON3
expression plasmid. Controls received the same vectors, but
without PON2/PON3 inserts. As expected, NF-κBp r o m o t e r
activity was signiﬁcantly increased 4- to 6-fold above con-
trol cells following PCN treatment (Figure 2). Importantly,
PON2 and PON3 overexpression caused a dramatic decrease
in activation of this major pathway involved in inﬂammatory
response.
Finally, because NF-κB has both pro- and anti-
inﬂammatory properties, we wished to determine which
cytokine is secreted from endothelial cells exposed to PCN
and if this was altered by paraoxonase overexpression. For
this purpose, we performed an ELISA with a panel of inﬂam-
matory cytokines by using cell supernatants from PCN-
treated na¨ ıve EA.hy 926 cells or cells overexpressing PON2-
GFP or PON3-GFP. By using this approach, we covered
several major inﬂammatory mediators, like IL-1A, IL-1B, IL-
2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17A, IFN-γ,T N F - α,a n d
GM-CSF. Remarkably, only one single cytokine was induced
byPCNinendothelial cells,namely,IL-8(>1000pg/mL);the
IL-8 level was about 6-fold higher in PCN treated compared
to untreated EA.hy 926 cells (Figure 3(a)). IL-8 release was
markedly lowered by PON2 or by PON3 overexpression
(about 2-fold to 4-fold, respectively; Figure 3(b)). Taken
together, PON2 and PON3 act as potent anti-inﬂammatory
enzymes, which is shown by their reducing eﬀects on ROS
production, NF-κB activation and IL-8 release in response to
P. aeruginosa virulence factor PCN.
3.2. 3OC12 Downregulates PON3 Hydrolytic Activity and
Protein. Besides the virulence factor PCN, P. aeruginosa
secrets the quorum sensing signal 3OC12, which can be
hydrolyzed and thus inactivated by PON2. In fact, it appears
that PON2 has a dominant role in 3OC12 hydrolysis [27].
Our further studies showed that PON2 hydrolytic activity,
mRNA, and protein are actively downregulated by 3OC12,
which disrupts PON2’s protection against both 3OC12 levels
and PCN-induced ROS production [24]. Given that PON3
diminished PCN-triggered ROS, it is worthwhile to address
eﬀects of 3OC12 on PON3 in a similar manner. To this
end, we addressed the eﬀect of 3OC12 on PON3 hydrolytic4 Journal of Lipids
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Figure 1: PON2 or PON3 overexpression diminishes ROS production induced by P. aeruginosa signaling molecule pyocyanin (PCN). (a)
Na¨ ıve, PON2-GFP, or PON3-GFP overexpressing HEK293 cells were loaded with carboxy-H2DCFDA and stimulated with PCN (2.4μM).
Carboxy-H2DCFDA ﬂuorescence as means of ROS was recorded over several hours. (b) Similar to A. Na¨ ıve, PON2-GFP, PON3-GFP, or
PON3-dsRed overexpressing EA.hy 926 cells were loaded with L-012 and stimulated with PCN (2.4μM). Curve maxima calculated by
nonlinear regression showed statistically signiﬁcant diﬀerences (P<0.001) between na¨ ıve and PON2 or PON3 overexpressing cells.
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Figure 2: PON2 or PON3 overexpression diminishes NF-κB activation induced by P. aeruginosa signaling molecule PCN. A549 cells
transiently overexpressing HA or PON2-HA (a) and GFP or PON3-GFP (b) were stimulated with PCN (100μM, 4h) and analyzed for
NF-κB activation. Symbols represent ± S.E.M. n = 6–9;
∗∗∗P < 0.001.
activity, mRNA, and protein. We used PON2-GFP or PON3-
GFP overexpressing HEK293 cells for measuring lactonase
or lovastatinase activity (for PON2 and PON3, resp.). In
a g r e e m e n tw i t hp r e v i o u so b s e r v a t i o n si no t h e rc e l ll i n e s ,
PON2 activity was rapidly decreased after 3OC12 treatment.
The PON2 hydrolytic activity was reduced by ∼50% in
10min and >80% in 30min (Figure 4(a)). Our previous
studies revealed that PON2 activity was inversely related to
intracellularCa2+-homeostasis,with3OC12hydrolysisbeing
depleted in response to Ca2+-release as it was inhibitable by
Ca2+-chelatorBAPTA[24].Interestingly,PON3lovastatinase
activity was also rapidly inactivated by 3OC12 to an almost
identical level as observed for PON2 (Figure 4(b)).
Our previous data demonstrated that 3OC12 caused a
pronounced calcium inﬂux in A549 and EA.hy 926 cells in a
very short time-interval. This formed the basis for an active,
calcium-dependentinactivationandsubsequentdegradation
of PON2. Therefore, we wanted to explore if PON3 is
also degraded in a calcium-sensitive manner, as this could
point to regulatory pathways shared by these two diﬀerentJournal of Lipids 5
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Figure 3: PCN induces IL-8 secretion, which can be lowered by PON2 or PON3 overexpression. (a) Na¨ ıve, PON2-GFP or PON3-GFP
overexpressing EA.hy 926 cells were treated with PCN (10μM, 16h). Cell supernatants were analyzed for the secretion of the listed cytokines
and chemokines by ELISA. (b) Quantitative evaluation of results from panel (a) Fold induction of IL-8 release was calculated between
untreated and PCN-treated samples.
enzymes [24]. To this end, we treated A549 cells with 3OC12
and analyzed PON3 mRNA levels by qRT-PCR at diﬀerent
time-points. Figure 5(a) shows a decrease of PON3 mRNA
after 16h 3OC12 treatment to ∼70%. Next we veriﬁed, if
PON3 mRNA is actively degraded or if the decrease results
from a discontinued transcription or reﬂection of normal
mRNA turnover. We treated A549 cells with 3OC12 or
the RNA synthesis inhibitor 5,6-dichlorobenzimidazole 1-β-
D-ribofuranoside (DRB), or combinations thereof. Unlike
PON2, PON3 mRNA was not actively degraded in response
to 3OC12 (Figure 5(b)).
Finally we performed Western blot analyses to monitor
PON3 protein levels after major Ca2+-disturbances caused
by treatment with 3OC12. For reasons of comparison,
we used the SERCA inhibitor thapsigargin, which also
causes serious Ca2+-disturbances. Treatment of A549 cells
with 3OC12 for diﬀerent durations showed that PON3
proteinleveldecreasedtimedependentlyandvanishednearly
completely after 16h; while PON2 protein was also degraded
by ∼50% after 16h (Figure 6(a)). In accordance, A549 cells
treated with diﬀerent thapsigargin concentrations showed a
signiﬁcant dose-dependent degradation of PON3 and PON2
(Figure 6(b)).
4. Discussion
P. aeruginosa infectionsarediﬃculttotreatsincethebacteria
often develop multiple antibiotic resistance and form a
bioﬁlm, which hinders the access of the antibiotics to the
bacteria. Additionally, P. aeruginosa secrets diﬀerent viru-
lence factors, which regulate the bacterial communication
and damage the infected host. Therefore, it is important
to understand P. aeruginosa host-pathogen interactions to
identify new potential therapeutic targets. Combined with
the knowledge gained in previous studies, our results suggest
that human paraoxonases PON2 and PON3 comprise a
major defense against virulence factor-induced oxidative
stress, inﬂammatory response, and cytokine release.
In this study, we revealed, for the ﬁrst time, the protective
eﬀect of PON3 against PCN-induced host cell damage. By6 Journal of Lipids
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Figure 4: PON2 and PON3 activity decrease after 3OC12 treatment. (a) PON2-GFP overexpressing HEK293 cells were treated with 3OC12
(100μM) for the indicated durations and tested for 3OC12-HSL hydrolytic activity. (b) PON3-GFP overexpressing HEK293 cells were
treated with 3OC12 (100μM) for the indicated durations and tested for lovastatinase hydrolytic activity. Symbols represent ± S.E.M. n = 3;
∗∗∗P < 0.001.
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Figure 5: PON3 mRNA is not actively degraded in response to 3OC12 treatment. (a) A549 cells were treated with 3OC12 (100μM) for the
indicated durations and analyzed for PON3 mRNA levels by qRT-PCR. (b) A549 cells were treated with 3OC12 (100μM, 24h) or with DRB
(100μM, 24h) or combinations thereof. There was no statistically signiﬁcant diﬀerence in PON3 mRNA levels after DRB or DRB/3OC12
treatment. Symbols represent ± S.E.M. n = 3;
∗∗∗P < 0.001 versus control.
various technical approaches and using diﬀerent cell lines,
we showed that PCN leads to ROS production, NF-κB-
activation, and IL-8 secretion, which can be prevented by
PON2 or PON3 overexpression. PCN induces the produc-
tion of O2
− and H2O2, which causes damage in various cell
types [10]. Overexpression of PON2 or PON3 in relevant
systems leads to a signiﬁcant reduction of ROS production,
reﬂecting the protective eﬀect of both enzymes against PCN-
induced oxidative damage. Importantly, PON2 and PON3
diﬀerintheirsubstratespeciﬁcities, asPON2hasadominant
lactonase activity, whereas PON3 has much better activity
with some large lactones or arylesters (i.e., statins; estradiol
acetates). Thus, we conclude that PON2 and PON3 act
by a common anti-oxidative mechanism. Intriguingly, our
data also suggest that the anti-oxidative eﬀect of PON3
is independent from its enzymatic activity. This would
be in agreement with previous results demonstrating an
independent anti-oxidative and hydrolytic activity of PON2
[22].Addressingtheunderlyinganti-oxidativemechanismof
PON2 and PON3, we and others recently showed that PON2
and PON3 localize to the inner mitochondrial membrane
where they interact with coenzyme Q10 (coQ10) resulting inJournal of Lipids 7
100
004488 1 6 1 6 Hours
PON3
PON2
50
0
04
Time (h)
PON2
PON3
81 6
P
r
o
t
e
i
n
 
l
e
v
e
l
 
(
%
)
α-tubulin
∗∗∗
∗∗∗
∗∗∗
∗∗
∗∗
(a)
100
50
0
013
Thapsigargin (nM)
10 100 30
P
r
o
t
e
i
n
 
l
e
v
e
l
 
(
%
)
PON2
PON3
0011 3 31 0 3 0 10 100 30 100 nM
PON3
PON2
α-tubulin
∗∗∗
∗∗∗
∗∗∗
∗∗∗ ∗∗∗
∗∗∗ ∗∗
(b)
Figure 6: Both PON2 and PON3 are degraded after 3OC12 treatment. (a) A549 cells were treated with 3OC12 (100μM) for the indicated
durations or (b) with thapsigargin (24h) with the indicated concentrations. Lysates (50μg of protein) were analyzed by Western blotting
usinganti-PON2,anti-PON3, or anti-α-tubulinantibodies. One representative blot is shown.Results (right)arethe means ± S.E.M. of three
replicate analyses;
∗∗P < 0.01;
∗∗∗P < 0.001.
abrogated superoxide production [16, 22, 23]. According to
thecurrent model (reviewedin this issue; [29]), it is assumed
that PON2 and PON3 protect against ROS formation by
acting as an insulator for coQ10 to prevent coincidental
superoxide production at the mitochondrial membrane.
It has also been reported that PCN increases IL-8
expression in human airway epithelial cells [28]. Similarly,
we observed an increase in IL-8 secretion by PCN in
endothelial EA.hy 926 cells. Interestingly, this can be lowered
by PON2 or PON3. Additionally, we monitored the release
of numerous proinﬂammatory cytokines and chemokines
after PCN treatment. None of the tested factors was induced
exceptforIL-8,suggestingthatIL-8actsasacentralmediator
of endothelial inﬂammation triggered by PCN. It is known
that IL-8 promoter activity and expression can be induced
by NF-κB[ 30, 31]. Our data also imply a role for NF-κBa s
mediator between PCN-induced eﬀects on ROS formation
and proinﬂammatory immune response by release of IL-
8. In particular, PCN was able to activate NF-κB, which
could be reduced by PON2 or PON3. It is fully established
that NF-κB is regulated by redox signaling. Taken together,
our data suggest that PON2 and PON3 anti-inﬂammatory
activities result from their ability to prevent ROS formation,
aslessoxidativestresslikelydiminishesNF-κBactivationand
subsequent IL-8 release.
Furthermore, we revealed the eﬀect of 3OC12 on PON3
hydrolytic activity, mRNA, and protein. PON3 mRNA, in
contrast to PON2 mRNA [22], was not actively degraded,
indicative of independent mechanisms that regulate stability
of these two mRNAs. PON3 protein levels were dramatically
decreased by 3OC12 treatment. A severely altered calcium
homeostasis as underlying mechanism appears highly likely,
as this has previously been demonstrated for PON2 [24].
OurdatamayalsosuggestthatPON2andPON3degradation
occursthroughthesameCa2+-mediat edpath wa y ,asitactsin
a similar time (in case of 3OC12) or dose-dependent (in case
of thapsigargin) manner. Similar to PON2, PON3 hydrolytic
activity was decreased much more extensively and rapidly
than the protein, indicating a likely posttranslational event
blocking PON2’s and PON3’s enzymatic function.
Our ﬁndings emphasize roles for PON2 and PON3
in the defense against P. aeruginosa virulence but show
also that the bacterium may circumvent the protection by
PON2 and PON3. Identiﬁcation of the posttranslational
modiﬁcation of PON2, which causes its inactivation and
induces the signaling pathway that mediates PON2 and
PON3 downregulation, may lead to the identiﬁcation of
an important therapeutic approach. It may be beneﬁcial
to block the 3OC12-mediated decrease of PON2 activity,
sustaining PON2’s protective eﬀect of inactivating 3OC12.
Given the high similarity of PON2 and PON3 and consid-
ering the fact that both proteins are inactivated by 3OC12-
mediated Ca2+-disturbances, the same regulatory posttrans-
lational modiﬁcation may reside in conserved position(s).
The distinct modiﬁcation remains to be determined, as
protein function can be altered by many modiﬁcations,8 Journal of Lipids
like methylation, acetylation, ubiquitinylation, and glyco-
sylation/deglycosylation. Our previous data showed that
PON2 inactivation is rapid and reversible, which would
be consistent with phosphorylation/dephosphorylation by
proteinkinases/phosphatases [24].Iftrue,about50potential
serine, threonine, and tyrosine phosphorylation residues
could be responsible for the (in-)activation of PON2. Hence,
future studies are needed to identify the precise mechanism
that regulates enzymatic activity of PON2 and PON3. Given
that inactivation occurs within minutes and the knowledge
that activity does not require cofactors (except for calcium),
thepresenceofaCa2+-triggered,regulatoryposttranslational
modiﬁcationappearshighlylikely.Revealingthismechanism
is of great interest, not only for protection against P. aerugi-
nosa virulence factors but also for activities of paraoxonases
beyond this speciﬁc interaction.
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